SCHEMBL24938544

SCHEMBL24938544

CCCCCCCC/C=C\CCCCCCCCC(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 8/20 0.53
CES1 P23141 2/20 0.53
TRPV1 Q8NER1 1/20 0.52
PLA2G4A P47712 2/20 0.47
MAPT P10636 3/20 0.46
BLM P54132 3/20 0.46
ALDH1A1 P00352 1/20 0.46
PLA2G4B P0C869 1/20 0.46
MGLL Q99685 1/20 0.46
PLA2G4C Q9UP65 1/20 0.46
TERT O14746 3/20 0.45
PTPN1 P18031 3/20 0.45
PPARG P37231 3/20 0.45
PPARD Q03181 3/20 0.45
PPARA Q07869 3/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 2/20 0.45
HSD17B10 Q99714 2/20 0.45
FABP4 P15090 2/20 0.45
KMT2A Q03164 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28417663 1.00 FAAH (0.53) FAAHCES1TRPV1PLA2G4AMAPT
SCHEMBL893646 0.91 PLA2G4A (0.57) FAAHTRPV1PLA2G4AMAPTBLM
SCHEMBL893644 0.91 PLA2G4A (0.57) FAAHTRPV1PLA2G4AMAPTBLM
SCHEMBL1428312 0.88 FAAH (0.41) FAAHCES1TRPV1PLA2G4AMAPT
SCHEMBL1818265 0.88 FAAH (0.50) FAAHCES1TRPV1PLA2G4AMAPT
SCHEMBL1818263 0.88 FAAH (0.50) FAAHCES1TRPV1PLA2G4AMAPT
SCHEMBL5324851 0.87 PLA2G4A (0.62) FAAHTRPV1PLA2G4AMAPTBLM
SCHEMBL1818264 0.86 ALDH1A1 (0.41) FAAHCES1TRPV1PLA2G4AMAPT
SCHEMBL11245962 0.86 TSHR (0.41) FAAHCES1TRPV1PLA2G4A
SCHEMBL1428313 0.86 FAAH (0.47) FAAHCES1TRPV1PLA2G4AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230023267-A1 OLEIC ACID DERIVATIVES AS TREATMENTS FOR FRIEDREICH ATAXIA AND INHIBITORS OF FERROPTOSIS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230023267-A1 OLEIC ACID DERIVATIVES AS TREATMENTS FOR FRIEDREICH ATAXIA AND INHIBITORS OF FERROPTOSIS AIFM2, ACOX1, ALOX12 FAAH 232/4885CES1 2527/4885TRPV1 3395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.